|
|
| Begins |
September 28, 2006
|
|
|
|
|
|
|
|
|
| Category |
Health: Pharmacy
|
|
|
|
|
|
|
| Contact |
800 Enterprise Road, Suite 200
Horsham, Pennsylvania
|
|
|
|
|
|
| Description |
DIA Webinar offer the power and punch of in-person events—all from the convenience of your home or office. This 90-minute, introductory webinar will outline the benefits of a finalized Best Practices Document for the Submission of Data in a Voluntary Genomics Data Submission (VGDS)—the perfect appetizer for DIA’s upcoming two-day workshop, “Best Practices and Development of Standards for the Submission of genomic Data to the FDA.”
Webinar Highlights:
Panel discussion and Q&A with FDA representatives.
Spirited discussion of the VGDS experience.
FEATURED TOPICS:
• Scientific accomplishments showcased in Voluntary Genomic Data Submissions (VGDS) over the past two years.
• Consensus from Q&A sessions about the added value of genomic data in regulatory review.
• New applications associated with VGDS, including other omic platforms and estimates for the impact of pharmacogenomic information in clinical trials.
• Role of VGDS in the Biomarker Qualification Pilot Process.
• Best Practices and Development of Standards in the Submission of Genomic Data to the FDA.
|
|
|
|
